2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Disease progression of spinocerebellar ataxia types 1, 2, 3, and 6 before and after ataxia onset: a joint analysis of two longitudinal cohort studies

H. Jacobi, T. Schaprian, M. Schmid, T. Klockgether (Heidelberg, Germany)
Disorder of bulk lipid transfer? Lipid composition and distribution in cellular models of VPS13A disease

K. Peikert, A. Spranger, E. Fischer, H. Glaß, B. Falkenburger, G. Miltenberger-Miltenyi, D. Tyteca, C. Klose, D. Grossmann, A. Hermann (Rostock, Germany)
Disruption of Locus Coeruleus-Related Functional Networks in Parkinson’s Disease

J. Sun, J. Ma, L. Gao, J. Wang, D. Zhang, L. Chen, J. Fang, T. Feng, T. Wu (Beijing, China)
Distinct characteristics of gut microbiome in patients with Parkinson’s disease according to the presence of premotor REM sleep behavior disorders

S. Jo, JY. Lee, JW. Bae, SJ. Chung (Seoul, Republic of Korea)
Distinct deep grey matter iron accumulation in tremoric syndromes; an apparent quantitative susceptibility mapping mangetic resonance study

A. Martín-Bastida, I. Aviles-Olmos, A. Gorospe-Osinalde, V. Suarez-Vega, P. Dominguez-Echavarri, R. García-Eulate, C. Sánchez-Catasús, MC. Rodríguez-Oroz (Pamplona, Spain)
Distinct striatal connectivity patterns in patients with Parkinson’s disease with and without urinary symptoms

N. Piramide, R. de Micco, F. Di Nardo, M. Siciliano, G. Caiazzo, G. Tedeschi, F. Esposito, A. Tessitore (Napoli, Italy)
Distinct temporal and spatial alteration of immunoproteasome in Parkinson’s Disease pathogenesis

HD. Nguyen, YE. Kim, TT. Lai, HN. Pham, IH. Kwak, H. Ma (Anyang, Gyeonggi-do, Republic of Korea)
DNA Methylation is associated with gene expression changes in sporadic Parkinson Disease in the PPMI cohort.

P. Gonzalez-Latapi, B. Bustos, T. Simuni, S. Lubbe, D. Krainc (Chicago, USA)
DNAJC12 defect a new neurodevelopmental disorder associated with parkinsonism-dystonia

F. Manti, G. Ricciardi, L. Pollini, C. Artiola, C. Carducci, MT. Carbone, D. Mei, F. Porta, A. Burlina, R. Guerrini, V. Leuzzi (Roma, Italy)
Does baseline expectation of benefit predict outcome in SURE-PD3, a Randomized, Double-Blind, Placebo-Controlled, Phase III trial of Inosine in Parkinson’s disease?

T. Mestre, E. Macklin, A. Lang, M. Schwarzschild (Ottawa, Canada)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z